Pre- and postoperative therapy with GnRH agonist for endometrial resection. A prospective, randomized study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 76, Issue 4, 1997, Pages 340-344

  Sørensen, Søren Stampe ^a   Colov, Nina Palmgren ^a   Vejerslev, Lars O ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

Dysmenorrhea; Endometrial ablation; Endometrial resection; GnRH agonist; Menorrhagia

Indexed keywords

GONADORELIN AGONIST; GOSERELIN;

ADULT; AMENORRHEA; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM ABLATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; MUSCLE CRAMP; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030960812     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0412.1997.tb07989.x     Document Type: Article

References (15)

1. Vercellini P, Bocciolone L, Colombo A, Vendola N, Meschia M, Bolis G. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas. Acta Obstet Gynecol Scand 1993; 72: 369-73.
2. Balasch J, Manau D, Mimo J, Duran M, Puerto B, Vanrell JA. Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma. Acta Obstet Gynecol Scand 1995; 74: 562-5.
3. Valle RF. Endometrial ablation for dysfunctional uterine bleeding: role of GNRH agonists. Int J Gynaecol Obstet 1993; 41: 3-15.
4. Sutton CJG, Ewen SP. Thinning the endometrium prior to ablation: is it worthwhile? Br J Obstet Gynaecol 1994; 101 (Suppl 10): 10-12.
5. Brooks PG, Serden SP, Davos I. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation. Am J Obstet Gynecol 1991; 164: 1601-8.
6. Serden SP, Brooks PG. Preoperative therapy in preparation for endometrial ablation. J Reprod Med 1992; 37: 679-81.
7. Scottish Hysteroscopy Audit Group. A Scottish audit of hysteroscopic surgery for menorrhagia: complications and follow up. Br J Obstet Gynaecol 1995; 102: 249-54.
8. Brooks PG, Serden SP. Preparation of the endometrium for ablation with a single dose of leuprolide acetate depot. J Reprod Med 1991; 36: 477-8.
9. Matta WHM, Stabile I, Shaw RW, Campbell S. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Busereline. Fertil Steril 1988; 49: 1083-5.
10. Jacobs SA, Blumenthal NJ. Endometrial resection follow up: late onset of pain and the effect of depot medroxyprogesterone acetate. Br J Obstet Gynaecol 1994; 101: 605-9.
11. Wortman M, Daggett A. Hysteroscopic endomyometrial resection: A new technique for the treatment of menorrhagia. Obstet Gynecol 1994; 83: 295-8.
12. Magos AL, Baumann R, Lockwood GM, Turnbull AC. Experience with the first 250 endometrial resections for menorrhagia. Lancet 1991; 337: 1074-8.
13. McCausland AM. Hysteroscopic myometrial biopsy: Its use in diagnosing adenomyosis and its clinical application. Am J Obstet Gynecol 1992; 166: 1619-28.
14. Istre O. Transcervical resection of endometrium and fibroids: The outcome of 412 operations performed over 5 years. Acta Obstet Gynecol Scand 1996; 75: 567-74.
15. Istre O, Schiötz H, Sadik L, Vormdal J, Vangen O, Forman A. Transcervical resection of endometrium and fibroids. Initial complications. Acta Obstet Gynecol Scand 1991; 70: 363-6.